Survival is changing the shape of cancer care

Australia’s cancer system has a success story that is creating a new policy challenge. More people are living after a cancer diagnosis, but many continue to need practical, physical and psychological support long after active treatment ends. A Flinders University-led paper published in the Medical Journal of Australia argues that the Medicare system needs to catch up with that reality.

The paper arrives as the Medicare Benefits Schedule Review Advisory Committee seeks feedback on a proposal to raise the annual number of Medicare-subsidized allied-health visits from five to 12. The proposed change would be the first major review of the cap in more than two decades. More than 1.6 million Australians are living with and beyond cancer, according to the researchers, making survivorship care an increasingly significant part of the health system rather than a narrow follow-up service.

The authors welcome the proposed increase, but say a higher visit cap alone will not resolve the gaps that patients encounter after treatment. Their central point is straightforward: surviving cancer does not necessarily mean a person has returned to their previous level of health, function or financial security.

The needs that persist after treatment

The paper identifies a broad set of problems that can remain for years after treatment, including fatigue, pain, sleep difficulties, anxiety, reduced physical function and financial stress. Those effects can interfere with daily life, work and a person’s ability to remain active. They also create demands that are not always met by a model focused primarily on diagnosis and acute treatment.

Lead author Carolyn Ee, an associate professor, academic general practitioner and cancer-survivorship researcher at Flinders University’s LiveWell Cancer Research Centre, says advances in treatment should be celebrated but should not be mistaken for a complete answer to patients’ needs. In the researchers’ view, the health system has not kept pace with the growing population living after cancer.

That gap matters because post-treatment support can span multiple professions. The paper points to physical therapy, exercise physiology, dietetics, occupational therapy and psychological care as allied-health services with evidence behind them. These disciplines address different dimensions of recovery: physical capacity, nutrition, day-to-day functioning and mental health. A visit limit that is too low can force patients to choose among needs that are interconnected.

Why the proposed cap is drawing support

Moving from five subsidized visits to 12 would give clinicians and patients more room to use services over the course of a year. For someone managing fatigue, pain and a gradual return to work, care may require more than a brief burst of appointments. The proposal is therefore relevant not only to symptom management but also to maintaining independence and quality of life.

The researchers cite strong evidence that allied-health support can improve outcomes for people living with cancer. Structured exercise programs, for example, have been shown in international studies to improve disease-free survival for some people after treatment for colon cancer. That finding does not mean a single service fits every cancer survivor, but it illustrates why access to rehabilitation and supportive care is more than an optional add-on.

Cost remains a central obstacle. Even where a service is clinically appropriate, out-of-pocket expenses and limited subsidized appointments can make it hard to obtain. Expanding Medicare support could reduce one barrier, especially for people whose cancer experience has also brought reduced income or ongoing expenses.

A policy change, not a finished solution

The Flinders-led analysis is careful not to present the 12-visit proposal as a cure-all. Increasing the cap is one component of a wider survivorship-care problem, the authors say. Patients may still face difficulties locating suitable services, coordinating care across providers and receiving support that matches their circumstances.

That framing is important for policymakers. A larger entitlement can improve access on paper, but its value depends on whether patients can use it in practice. Survivorship care also needs to recognize that cancer’s effects are not limited to one specialty or one stage of recovery. Needs can change over time, and they can involve the body, emotional wellbeing, work and household finances at once.

The public consultation gives Australia an opportunity to reconsider a longstanding Medicare limit in light of a changing patient population. The research makes the case that a system designed around treatment completion should evolve toward a system that also supports life after treatment. For the growing number of Australians who have survived cancer, the outcome of that debate could determine whether recovery is treated as a short administrative phase or as an essential part of care.

This article is based on reporting by Medical Xpress. Read the original article.

Originally published on medicalxpress.com